Manufacturer record
Wings Biotech LLP: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
22 batches manufactured by Wings Biotech LLP (Himachal Pradesh) were declared Not of Standard Quality between October 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CEXD-1074, Cefixime Oral Suspension I.P. (exp Nov 2026). SDT&RL, Bhubaneswar (state lab) found it not of standard quality: Content for Anhydrous Cefixime. Listed in the August 2026 alert.
Records by type
22 records linked to Wings Biotech LLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime Oral Suspension I.P. | Batch CEXD-1074Mfg Jun 2025 · Exp Nov 2026 | Content for Anhydrous CefiximeOther | SDT&RL, BhubaneswarState lab | Aug 2026 |
| Ibuprofen Tablets I.P. 400 mg | Batch IBPT-1003Mfg Jul 2024 · Exp Jun 2027 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.Dissolution | RDTL, GuwahatiCDSCO lab | Jul 2026 |
| Ibuprofen Tablets IP 400 mg | Batch IBPT-1002Mfg Jul 2024 · Exp Jun 2027 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Rosuvastatin Tablets IP 20 mg | Batch RVST-1040Mfg Nov 2025 · Exp Oct 2027 | The sample does not conform to I.P with respect to the test for Related substancesRelated substances | CDL, KolkataCDSCO lab | May 2026 |
| Ondansetron Tablets IP | Batch ONST-1006Mfg Jul 2026 · Exp Jun 2027 | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the test of Dissolution.Dissolution | RDTL, ChandigarhCDSCO lab | May 2026 |
| Glimepiride, Pioglitazone Hydrochloride and Metformin Hydrochloride Sustained-release Tablets (2mg/15mg/500mg) | Batch GMPT-1050Mfg Jan 2024 · Exp Dec 2025 | Assay for Glimepiride" onlyAssay | RDTL, Hubli, KarnatakaState lab | Nov 2025 |
| Lindane Lotion USP 1% | Batch LNE-1020Mfg Aug 2025 · Exp Jul 2027 | The above product is official in IP 2022 (Addendum 2024 W.e.f july 2024) but it is claimed as USP as on Manufacturing date.Other | SDTL, PunjabState lab | Oct 2025 |
| Telmisartan and Hydrochlorothizide Tablets I.P (40mg/12.5mg) | Batch TMHT-1037Mfg Oct 2023 · Exp Sep 2026 | Uniformity of WeightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Telmisartan and Hydrochlorothiazide Tablets I.P (40mg/12.5 mg) | Batch TMHT-1012Mfg Sep 2023 · Exp Aug 2026 | Uniformity of weightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Telmisartan and Hydrochlorothiazide Tablets I.P. (40mg/12.5mg) | Batch TMHT1046Mfg Oct 2023 · Exp Sep 2026 | Uniformity of WeightUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Ondansetron Oral Solution I.P. 2mg/5ml | Batch ONES-1004Mfg Sep 2024 · Exp Aug 2026 | Related SusbtancesOther | CDL KolkataCDSCO lab | Apr 2025 |
| Norfloxacin Tablets I.P. 400mg. | Batch NFXT-1002Mfg Jun 2023 · Exp May 2026 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Feb 2025 |
| DICLOFENAC SODIUM AND PARACETAMOL TABLETS I.P (DiCLOWiN PLUS) | Batch DPT- 5765Mfg ? · Exp ? | Does not comply with respect to Assay for Diclofenac sodium -NSQAssay | PuducherryState lab | Feb 2025 |
| Paracetamo l, Cetirizine Hydrochlori de & Phenylephri ne Hydrochlori de Tablets (WINCOLD Z) | Batch WNZT- 3240Mfg Nov 2023 · Exp Oct 2026 | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration - NSQDescription | State Lab PuducherryState lab | Jan 2025 |
| Aceclofast | Batch 60Mfg Nov 2023 · Exp Oct 2025 | Sample does not conform to Label claim with respect to the content of Aceclofenac and it contains DiclofenacDiethylamine which is not declared on the label.Labelling | DTL ChennaiState lab | Nov 2024 |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP 10 mg/5 mg | Batch MLHT-1022Mfg Sep 2023 · Exp Aug 2026 | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Oct 2024 |
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | Batch CPXT-1016Mfg Oct 2023 · Exp Sep 2026 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Jul 2024 |
| Prednisolone Tablets IP 10 mg | Batch PRDT- 1007Mfg Nov 2024 · Exp Oct 2024 | Assay of PrednisoloneAssay | RDTL ChandigarhCDSCO lab | Jun 2024 |
| Dexamethasone Tablets I.P. 0.5mg | Batch DXMT-1003Mfg May 2020 · Exp Apr 2023 | AssayAssay | RDTL GuwahatiState lab | May 2022 |
| FEXOFENADINE HYDROCHLORIDE TABLETS IP | Batch FXNT-1009Mfg Nov 2020 · Exp Oct 2022 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | May 2021 |
| (CALCIUM AND VITAMIN D3 TABLETS IP) | Batch CVDT-1371Mfg Apr 2019 · Exp Mar 2021 | Dissolution of Calcium CarbonateDissolution | RDTL ChandigarhCDSCO lab | Jul 2020 |
| Calcium Carbonate Tablets IP | Batch CBRT-1041Mfg Apr 2019 · Exp Mar 2021 | Uniformity of weightUniformity of weight/content | RDTL ChandigarhCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.